Molecular Pharmacology (USA), Ltd. MLPH Company Overview 

New Post Public Reply Private Reply Replies (0) Message Board
Rosner
Molecular Pharmacology (USA), Ltd. MLPH Company Overview 

Stock Message Board http://investorshangout.com/search?q=MLPH&...mp;yt1=Go!

Molecular Pharmacology (USA), Ltd. MLPH Current Price and Quotes
0.017
Previous Close
0.019
Open
0.017

Daily Range
0.017 - 0.017
52wk Range
0.05 - 0.0081

Volume
10,000
Dividend
N/A

Average Vol (3m)
39,135
Yield
N/A

Molecular Pharmacology (USA), Ltd. MLPH
Company Information
Drug Discovery Research Centre
284 Oxford Street
Leederville
Perth, WA 6007
Australia

Website: http://www.mpl-usa.com
Phone: 011-61-8-9443-3011

Molecular Pharmacology (USA), Ltd. MLPH
Not Available

Molecular Pharmacology (USA), Ltd. MLPH
Financial Reportings and Disclosures
Reporting Status U.S. Reporting: SEC Filer
Audited Financials Audited
Latest Report Jun 30, 2013 10-K
CIK 0001191357
Fiscal Year End 6/30
OTC Marketplace OTCQB
Profile Data
SIC - Industry Classification 2834 - Pharmaceutical preparations
Business Status Development Stage Company a/o Mar 31, 2008
Incorporated In: NV, USA
Year of Inc. Not Available
Employees Not Available
Company Officers/Contacts
Jeffrey Edwards President, CEO
Simon Watson CFO, Secretary
Company Directors
Jeffrey Edwards
Simon Watson
Company Notes
Formerly=Blue Hawk Ventures, Inc. until 8-05
Service Providers
Auditor/Accountant
Not Available
Legal Counsel
Venture Law Corporation
688 West Hastings Street
Vancouver, BC, V6B 1P1
Canada

Investor Relations Firm
Not Available

Molecular Pharmacology (USA), Ltd. MLPH
MLPH Security Details
Share Structure
Market Value1 $1,896,414 a/o Aug 30, 2013
Shares Outstanding 111,553,740 a/o Aug 13, 2013
Float Not Available
Authorized Shares 300,000,000 a/o Mar 31, 2008
Par Value  0.001
Shareholders
Shareholders of Record 19 a/o Sep 24, 2010
Security Notes
Capital Change=shs increased by 4 for 1 split. Ex-date=08/29/2005.
Short Selling Data
Short Interest 0 (-100%)
Aug 15, 2012
Significant Failures to Deliver  No
Transfer Agent(s)
Pacific Stock Transfer Co.

Molecular Pharmacology (USA), Ltd. MLPH Recent News

Molecular Pharmacology (USA), Ltd. MLPH Financials
Period Ending Jun 30, 2013 Jun 30, 2012 Jun 30, 2011 Jun 30, 2010
Total Revenue - - - -
Cost of Revenue - - - -
Gross Profit - - - -
Operating Expenses
Research and Development - - - -
Sales, General and Admin. 209 179 121 116
Non-Recurring Items - - - -
Other - - 1 1
Operating Income (209) (179) (122) (117)
Income From Continuing Operations
Add'l Income/Expense Items (1) - - -
Earnings Before Interest and Tax (210) (179) (122) (117)
Interest Expense - - - -
Earnings Before Tax (210) (179) (122) (117)
Income Tax - - - -
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations (210) (179) (122) (117)
Non Recurring Events
Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income (210) (179) (122) (117)
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders (210) (179) (122) (117)

MLPH Molecular Pharmacology (USA), Ltd. Research DD Guide

MLPH Molecular Pharmacology (USA), Ltd. Stock Message Board http://investorshangout.com/search?q=MLPH&...mp;yt0=Go!
MLPH Molecular Pharmacology (USA), Ltd. Stock Quote http://www.otcmarkets.com/stock/MLPH/quote
MLPH Molecular Pharmacology (USA), Ltd. Stock Chart http://www.otcmarkets.com/stock/MLPH/chart
MLPH Molecular Pharmacology (USA), Ltd. Company Info http://www.otcmarkets.com/stock/MLPH/company-info
MLPH Molecular Pharmacology (USA), Ltd. Recent News http://www.otcmarkets.com/stock/MLPH/news
MLPH Molecular Pharmacology (USA), Ltd. Financials http://www.otcmarkets.com/stock/MLPH/financials
MLPH Molecular Pharmacology (USA), Ltd. Filings and Disclosure http://www.otcmarkets.com/stock/MLPH/filings
MLPH Molecular Pharmacology (USA), Ltd. Short Sales http://www.otcmarkets.com/stock/MLPH/short-sales
MLPH Molecular Pharmacology (USA), Ltd. Insider Disclosure http://www.otcmarkets.com/stock/MLPH/insider-transactions
MLPH Molecular Pharmacology (USA), Ltd. Research Reports http://www.otcmarkets.com/stock/MLPH/research
MLPH Molecular Pharmacology (USA), Ltd. Summary http://finance.yahoo.com/q?s=MLPH
MLPH Molecular Pharmacology (USA), Ltd. Historical Prices http://finance.yahoo.com/q/hp?s=MLPH+Historical+Prices
MLPH Molecular Pharmacology (USA), Ltd. Interactive Chart http://finance.yahoo.com/echarts?s=MLPH
MLPH Molecular Pharmacology (USA), Ltd. Basic Chart http://finance.yahoo.com/q/bc?s=MLPH+Basic+Chart
MLPH Molecular Pharmacology (USA), Ltd. Basic Tech. Analysis http://finance.yahoo.com/q/ta?s=MLPH+Basic+Tech.+Analysis
MLPH Molecular Pharmacology (USA), Ltd. Headlines http://finance.yahoo.com/q/h?s=MLPH+Headlines
MLPH Molecular Pharmacology (USA), Ltd. Press Releases http://finance.yahoo.com/q/p?s=MLPH+Press+Releases
MLPH Molecular Pharmacology (USA), Ltd. Company Profile http://finance.yahoo.com/q/pr?s=MLPH+Profile
MLPH Molecular Pharmacology (USA), Ltd. Key Statistics http://finance.yahoo.com/q/ks?s=MLPH+Key+Statistics
MLPH Molecular Pharmacology (USA), Ltd. Industry http://finance.yahoo.com/q/in?s=MLPH+Industry
MLPH Molecular Pharmacology (USA), Ltd. Major Holders http://finance.yahoo.com/q/mh?s=MLPH+Major+Holders
MLPH Molecular Pharmacology (USA), Ltd. Insider Transactions http://finance.yahoo.com/q/it?s=MLPH+Insider+Transactions
MLPH Molecular Pharmacology (USA), Ltd. Insider Roster http://finance.yahoo.com/q/ir?s=MLPH+Insider+Roster
MLPH Molecular Pharmacology (USA), Ltd. Income Statement http://finance.yahoo.com/q/is?s=MLPH
MLPH Molecular Pharmacology (USA), Ltd. Balance Sheet http://finance.yahoo.com/q/bs?s=MLPH
MLPH Molecular Pharmacology (USA), Ltd. Cash Flow http://finance.yahoo.com/q/cf?s=MLPH+Cash+Flow&annual
MLPH Molecular Pharmacology (USA), Ltd. Nasdaq http://www.nasdaq.com/symbol/MLPH
MLPH Molecular Pharmacology (USA), Ltd. Market Watch http://www.marketwatch.com/investing/stock/MLPH
MLPH Molecular Pharmacology (USA), Ltd. Bloomberg http://www.bloomberg.com/quote/MLPH:US
MLPH Molecular Pharmacology (USA), Ltd. Morningstar http://quotes.morningstar.com/stock/s?t=MLPH
MLPH Molecular Pharmacology (USA), Ltd. Bussinessweek http://investing.businessweek.com/research/st...icker=MLPH
MLPH Molecular Pharmacology (USA), Ltd. Barchart http://www.barchart.com/quotes/stocks/MLPH
MLPH Molecular Pharmacology (USA), Ltd. OTC Short Report http://otcshortreport.com/index.php?index=MLPH
MLPH Molecular Pharmacology (USA), Ltd. Investopedia http://www.investopedia.com/markets/stocks/MLPH/?wa=0

List of all stock message boards and tickers for OTC BB Pinks & Penny Stocks http://investorshangout.com/board?categoryid=OTC
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Savvas Launches Miller & Levine Biology Program Revamp

Updated Category News Views 35

Education Meets Innovation: Savvas Takes a Bold Step Who would have thought biology education could get a makeover that might actually stick? Savvas Learning Company thinks it's onto something with the launch of the all-new Miller & Levine Experience Biology Program. The spotlight's on innovation—it's about time someone shook up the way high schoolers learn biology. A...

Continue Reading
Factory-Built Homes Take Center Stage in New Doc Short

Updated Category News Views 88

Housing is one of those things we all think we understand until we start peeling back the layers of its history, especially when factory-built homes are involved. Here's a new angle: Clayton has just released the teaser for their documentary short, "Built: A Story of Factory-Built Housing in America," and it's turning the lights on a sector that's often left in the...

Continue Reading
transcosmos: Not Just Calls—Evolving Business Strategy

Updated Category News Views 110

Turning Talk into Triumphs Award chatter isn't exactly rare in this industry, but the latest accolades rolling in for transcosmos from the Best Contact Center Indonesia 2026 ain't your run-of-the-mill pat on the back. Sure, a trophy's a trophy, but when they snatch Gold in the Business Contribution category and another shiny Silver in People Development, it’s hinting at...

Continue Reading
Unicycive Faces Legal Heat: Shareholder Lawsuit Looms

Updated Category News Views 104

The Unicycive Landslide: What Went Down? Investors, buckle up. Unicycive Therapeutics Inc. (NASDAQ: UNCY) finds itself deep in the muck of a securities class action. Chief honchos, CEO Shalabh Gupta and CFO John Townsend, are taking the heat for allegedly controlling company disclosures that led shareholders to believe in non-existent progress with their third-party...

Continue Reading
SoftwareOne Triumphs in 2026 GitHub Partner Awards

Updated Category News Views 43

SoftwareOne Nabs Prestigious GitHub Honor Outta nowhere, SoftwareOne's been lashed onto the center stage, bagging GitHub's Global Channel Sales Partner of the Year for 2026. This ain't just another shiny trophy on the shelf; it's a solid nod to their grit and strategy. Now, if good old GitHub says you're their top dog, you're obviously doing something right. Not bad for a...

Continue Reading
Data Centers Drive Surge in Power and Cooling Demand

Updated Category News Views 23

Data Centers: The Unseen Powerhouses Don't let the tech jargon fool you—data centers are more than just server rooms. They're beastly energy guzzlers, and their demand is rippling through the supply chain in a big way. You've got companies like Vertiv, American Tower, Johnson Controls, and Generac riding high on this trend, making some serious waves in their quarterly...

Continue Reading
Data Breach at Lumara Bio: Privacy Lawsuits Loom

Updated Category News Views 28

Another Day, Another Data Breach It seems like you can’t throw a stone without hitting a data breach these days—and this time, it’s Lumara Bio USA’s turn under the spotlight. The Princeton-based oncology therapeutics outfit, part of Germany’s ITM Isotope Technologies, spilled some beans it never meant to. We're talking some pretty sensitive stuff here, folks....

Continue Reading
Jacobi's Harness Brings AI from Concept to Reality

Updated Category News Views 160

The Challenge of Moving AI to Production Diving headfirst into AI in finance? Well, Jacobi's bold move with their new toy, the Investment Management Harness, spotlights a filthy secret: the hurdles between a big idea and execution are seldom technological. We got AI shaving prototyping time down to just days, yet pushing to production? That's a marathon in itself. Boards...

Continue Reading
Air Canada-CAE Scholarship Drives Women in Aviation

Updated Category News Views 88

A New Chapter for Women in Aviation Call it paving the skies or busting the glass cockpit ceiling, but Air Canada and CAE are really doubling down on getting more women into aviation. They're rolling out the eighth annual Captain Judy Cameron Scholarship, set to open applications on November 1, 2026. With up to eight scholarships on the table for Canadian women eyeing...

Continue Reading
H.R. 10549: Hope Charities Pushes for Pharmacy Freedom

Updated Category News Views 63

Hope Charities Takes a Stand for Patients In Prairieville, Hope Charities is throwing its weight behind a bill they believe is brewing up a patient revolution. The Patients Choice in Specialty Pharmacy Act, otherwise known as H.R. 10549, sparked by Representatives Neal Dunn and Joe Wilson, tackles the comfortable partnerships some insurers have been enjoying with their...

Continue Reading

Top 5 Most Recently Viewed Articles

Innovative AI Assistant by ClickBid Revolutionizes Fundraising

Updated Category News Views 155

ClickBid Introduces Groundbreaking AI Assistant ClickBid, recognized as a pioneer in event fundraising technology, proudly presents ClickBid Search. This is the first custom GPT-powered AI assistant tailored specifically for nonprofits, designed to offer immediate and relevant answers to help organizations optimize their event strategies. Available at no cost to all...

Continue Reading
TIER IV and TUM Drive Level 4 Autonomous Cars

Updated Category News Views 25

Autonomous Driving Gets a German Boost Well folks, looks like the autonomous vehicle scene is hitting the autobahns with more horsepower than ever before. Today’s chatter is all about how TIER IV and the Technical University of Munich (TUM) have teamed up, tapping into the grid as they ride the waves of cutting-edge NVIDIA tech. The Sparks Under the Hood: NVIDIA...

Continue Reading
Vericel Corporation's Upcoming Presentation at MedTech Conference

Updated Category News Views 147

Vericel Corporation's Engagement at the MedTech Conference CAMBRIDGE, Mass. — Vericel Corporation (NASDAQ:VCEL), a recognized leader in advanced therapies for sports medicine and severe burn care, has exciting news regarding its participation at the upcoming Truist Securities MedTech Conference. The company will be featured in a fireside chat, slated to take place at...

Continue Reading
Gildan Achieves Strong Q2 Results: Revenue and Finances Surge

Updated Category News Views 128

Gildan Reports Remarkable Growth in Second Quarter Earnings Gildan Activewear Inc. (NYSE: GIL, TSX: GIL) has achieved record net sales of $919 million during the second quarter, reflecting a strong 6.5% increase compared to the previous year. Strong Operational Performance and Profitability This quarter's operating margin stood at an impressive 21.7%, with an adjusted...

Continue Reading
MimiVax and UI Pharmaceuticals Mark Key Production Milestone

Updated Category News Views 260

MimiVax and UI Pharmaceuticals Mark Key Production Milestone MimiVax and UI Pharmaceuticals have achieved an exciting development in the field of cancer treatment with the clinical manufacture of SurVaxM, an innovative immunotherapeutic vaccine aimed at targeting glioblastoma. SurVaxM proudly stands out as the first product to be manufactured at UI Pharmaceuticals' newly...

Continue Reading